Regen BioPharma, Inc. Responds to Numerous Requests for Updates on its Intellectual Property (IP) Portfolio
via: Prnewswire
Regen Biopharma Inc0.000.00(7.23%)
Watch
Regen Biopharma IncOTC Updated Jun 8, 2022 12:47 PM
RGBP0.00
0.00 (7.23%)
11,553
Watch
7.23%
Price
1.06%
Sentiment
0.35%
Message Volume
1D
1W
1M
3M
6M
1Y
ALL
Filter by:
All
Real-Time
Cdrbo00
Bullish
12m
$RGBP
nice little end of the day bump ,
Take it !!
3
Invest in the Innovative Companies Building the Future
Tech-driven startups are transforming most sectors. Alumni Ventures helps thousands invest in portfolios of competitive, pre-IPO startups.
Sign up.
Sponsored by: Alumni Ventures
DarkKnightTrader1
16m
$RGBP
When I get paid Friday I'm buying 400,000 more shares to put me over a million. LFG !!! Hoping for buyout, like Eli Lilly maybe.
2
DigitalEye
Bullish
58m
$RGBP
higher lows baby, let’s go ????
8
CandlesINFLATED
59m
$RGBP
I need 2 million more
2
Rich1979
Bullish
12:09 PM
$RGBP
imagine the day we appear in this acquisition overview :)
en.wikipedia.org/wiki/List_...
1
6
Willwork4RGBPP
12:01 PM
$RGBP
?? ?? ?? ?? ?? ??
1
Vdiresta13
Bullish
12:01 PM
$RGBP
power hour? Been way too long…
2
Plus
bay8605
Bullish
11:52 AM
$RGBP
Some big numbers moving
13
13
The Potential of Investing in Pre-IPO Startups
Many investors choose venture to get into high-growth startups. Alumni Ventures makes it easy to own a professional VC portfolio.
Get started.
Sponsored by: Alumni Ventures
Kreenday
Bullish
11:26 AM
$RGBP
I know things are quiet right now and all yall fellow longs are locked in, I'm just adding to my list of posts that I will copy and paste for all the noobs whenever that volume comes pouring in and the wheels are in motion.. so don't judge.. lol
11
FUCancer
Bullish
10:54 AM
$RGBP
Respect is what i have for a lot of you, contributing to a strangers request.
Happy hump day!!
11
Kreenday
Bullish
10:51 AM
$RGBP
mRNA Tech= Success ??
Immuno-therapies to treat cancer =Success??
Checkpoint Inhibitors = Success??
Regens extensive IP Portfolio pertains to all of this
prnewswire.com/news-release...
Our headlining drug TCellVax has a checkpoint inhibitor utilizing mRNA tech ... A first in-class drug.
"The Company intends to combine modified mRNA technology with Regen's existing siRNA ( small interfering RNA) intellectual property targeting the NR2F6 nuclear receptor which has been identified as a potentially very important immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator."
prnewswire.com/news-release...
